Clinical trials for Catastrophic antiphospholipid syndrome
21 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07458984FMT Capsules for rCDIHelsinki University Central Hospital · PI: Perttu Arkkila, Professor
- RECRUITINGPhase 1NCT07297199A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55Biogen · PI: Medical Director
- RECRUITINGPhase 3NCT07165951Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- RECRUITINGN/ANCT07561333Comparing ACB+IPACK and ACB+BiFeS Block Combinations for Analgesia in Total Knee ArthroplastyHitit University · PI: Guvenc DOGAN, MD
- RECRUITINGPHASE2, PHASE3NCT06841679Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction AdenocarcinomaBeijing Biostar Pharmaceuticals Co., Ltd.
- RECRUITINGPhase 1NCT07044271A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy ParticipantsEli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
- RECRUITINGPhase 1NCT06943677A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- RECRUITINGPhase 2NCT06822946Zhibitai Capsules for the Treatment of Primary HyperlipidemiaChengdu Diao Jiuhong Pharmaceutical Factory
- RECRUITINGPhase 1NCT06796699A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid TumorsSuzhou Genhouse Bio Co., Ltd.
- RECRUITINGN/ANCT06837246A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General PopulationPharmavite LLC
- RECRUITINGPhase 1NCT06717269Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 TabletsNurix Therapeutics, Inc. · PI: Study Director
- RECRUITINGPhase 2NCT06458413Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast CancerMin Yan, MD
- RECRUITINGN/ANCT06526767Comparative Study of Different Dosages of Vibrabot Capsule in the Treatment of Chronic Functional ConstipationBeijing Tsinghua Chang Gung Hospital · PI: Xuan Jiang, Professor
- RECRUITINGPhase 3NCT06685978Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsTasly Pharmaceutical Group Co., Ltd
- RECRUITINGPhase 2NCT06490484Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to PregabalinHaisco Pharmaceutical Group Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT06306456A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLCSuzhou Genhouse Bio Co., Ltd. · PI: Caicun Zhou, Doctorate
- RECRUITINGPhase 1NCT06298409Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®Envivo Bio Inc · PI: George Triadafilopoulos
- RECRUITINGPHASE1, PHASE2NCT05773820A Study Explore WJB001 Capsules in Patients With Advanced Solid TumorsWigen Biomedicine Technology (Shanghai) Co., Ltd. · PI: Lingying Wu, Professor
- ACTIVE NOT RECRUITINGPhase 3NCT03866499A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer PatientsBeta Pharma Shanghai · PI: Yuankai Shi
- ACTIVE NOT RECRUITINGPhase 1NCT04685473Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid TumorsTaivex Therapeutics Corporation
- ACTIVE NOT RECRUITINGPhase 3NCT04523272A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerChia Tai Tianqing Pharmaceutical Group Co., Ltd.